다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

HOOK

HOOKIPA Pharma (HOOK)

HOOKIPA Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HOOK

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	20:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/05/09	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/05/09	20:01	GlobeNewswire Inc.	HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/25	20:01	GlobeNewswire Inc.	HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/24	20:01	GlobeNewswire Inc.	HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/17	05:30	GlobeNewswire Inc.	HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/04/10	20:01	GlobeNewswire Inc.	HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/03/22	20:01	GlobeNewswire Inc.	HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/03/06	21:01	GlobeNewswire Inc.	HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/02/01	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/29	22:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/29	22:01	GlobeNewswire Inc.	HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/16	21:01	GlobeNewswire Inc.	HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization	NASDAQ:HOOK	HOOKIPA Pharma Inc
2024/01/05	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/22	21:33	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/21	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/21	21:01	GlobeNewswire Inc.	HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/12/02	06:46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/20	21:01	GlobeNewswire Inc.	HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/09	21:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/09	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/09	21:01	GlobeNewswire Inc.	HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/04	01:01	GlobeNewswire Inc.	HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/11/03	05:01	GlobeNewswire Inc.	HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/10/22	19:01	GlobeNewswire Inc.	HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/10/21	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/10/18	20:01	GlobeNewswire Inc.	HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/09/13	21:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/09/13	21:45	GlobeNewswire Inc.	HOOKIPA Announces Executive Leadership Change	NASDAQ:HOOK	HOOKIPA Pharma Inc
2023/09/12	21:01	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:HOOK	HOOKIPA Pharma Inc

검색 관련기사 보기:NASDAQ:HOOK

1 2 3 4 5 6 7 8 9 10 다음 >>

Financial Select Sector

Gold vs US Dollar

US Dollar vs Yen

JP Morgan Chase

Energy Select Sector SPDR

Health Care Select Sector

Verizon Communications

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관